3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow End-Stage Renal Disease (ESRD): new trials by email Literature Review of End-Stage Renal Disease (ESRD) trials Research Report on End-Stage Renal Disease (ESRD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Avacopan in Participants With Normal Renal Function and Participants With End-Stage Renal Disease (ESRD) Avacopan - End-Stage Renal Disease (ESRD) | Phase 1 | Completed | Amgen | 13 | 2024-06-18 | 2026-09-11 |
| Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012) MK-2060, Placebo - End-Stage Renal Disease (ESRD), End-Stage Kidney Disease (ESKD) | Phase 1 | Completed | Merck Sharp & Dohme LLC | 17 | 2023-06-14 | 2025-03-14 |
| Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders BIV009, Placebo - Bullous Pemphigoid (BP), Cold Agglutinin Disease (CAD) | Phase 1 | Completed | Bioverativ, a Sanofi company | 122 | 2015-07-13 | 2022-04-25 |
Kidney Failure, Chronic (3) · Anemia, Hemolytic, Autoimmune (1) · Pemphigoid, Bullous (1)
Chronic Disease (3) · Disease Attributes (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Renal Insufficiency (3) · Renal Insufficiency, Chronic (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Anemia (1) · Anemia, Hemolytic (1) · Autoimmune Diseases (1)
Saline Solution (2) · avacopan (1)
Amgen (1) · Bioverativ, a Sanofi company (1) · Merck Sharp & Dohme LLC (1)
Austria (1) · Japan (1) · United States (1)
PMID 27716293, PMID 28926521, PMID 28980446, PMID 30559259, PMID 38995690
2014 (1)